explore -WSS

explore

author：Wikipedia 2025-09-05 03:01:13 - browse：53833

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： As Maui death toll rises, number of missing remains unclear

explore

WSS

Abbott's new heart device gets FDA advisory panel nod

STAT Boddities: What happens to the brain when we get scared?

An interview with Robert F. Kennedy Jr. on vaccines

As Maui death toll rises, number of missing remains unclear

Clinical trials must include more disabled people

Majority of Americans think Trump's Ga. election interference case is serious: POLL

knowledge

explore

focus

Medical records are filled with copy

An interview with Robert F. Kennedy Jr. on vaccines

After affirmative action ruling, medical educators look to 'holistic review'

Congress considering partial increase for doctor pay in Medicare

In age of alternative facts, a scholarly course on calling out crap

Doctors on social media are being harassed and cyberbullied

Duchenne breakthrough therapy leaves behind pioneering families

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

DIEP, the 'gold standard' of breast reconstruction, is under threat

Patient advocates sound warning on FDA proposal on salt intake

hotspot

AMAs digital advisors table RPM coding reform proposal, again

Why Eli Lilly’s earnings didn’t quite live up to the hype

An interview with Robert F. Kennedy Jr. on vaccines

Too many hospitalized Covid

STAT Boddities: What happens to the brain when we get scared?

New details revealed about Purdue's marketing of OxyContin

knowledge

knowledge

explore

focus